@article{5c59fb6a469e4df5b370e463d5842a88,
title = "Stem cell therapy for Alport syndrome: The hope beyond the hype",
keywords = "Alport syndrome, Bone marrow transplantation, Renal fibrosis, Stem cell therapy",
author = "Oliver Gross and Borza, {Dorin Bogdan} and Anders, {Hans Joachim} and Christoph Licht and Manfred Weber and Stephan Segerer and Roser Torra and Gubler, {Marie Claire} and Laurence Heidet and Scott Harvey and Dominic Cosgrove and George Lees and Clifford Kashtan and Martin Gregory and Judy Savige and Jie Ding and Paul Thorner and Abrahamson, {Dale R.} and Corinne Antignac and Karl Tryggvason and Billy Hudson and Miner, {Jeffrey H.}",
note = "Funding Information: Conflict of interest statement. C.K. is the executive director of the Alport Syndrome Treatments and Outcomes Registry (ASTOR), USA. O.G. is the principal investigator of the European Alport therapy registry, supported by the Association pour l`Information et la Recherche sur les maladies r{\'e}nale G{\'e}n{\'e}tiques France and the KfH-Foundation Preventive Medicine.",
year = "2009",
month = mar,
doi = "10.1093/ndt/gfn722",
language = "English",
volume = "24",
pages = "731--734",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
number = "3",
}